Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Aldesleukin
(Recombinant human interleukin-2)		[3] Aldesleukin; ILT-101; Recombinant human interleukin-2[1] Aldesleukin (Interleukin-2) 💬 [3] IL2RA,
IL2RB,
IL2RG 💬 		[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[6] 2, 35, 49, 65, 96, 97 💬
2 Human interleukin-2
(Liposome encapsulated recombinant interleukin-2)		[2] IL-2; Interleukin-2---[12] 2, 13, 46, 49, 50, 51, 53, 55, 65, 96, 97, 162 💬
3 PEG-interleukin-2
(Polyethylene glycol-modified recombinant interleukin-2)		[1] PEG-interleukin-2---[1] 65 💬